通过TREX1定位释放cGAS-STING途径的治疗潜力
1Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina.
Cancer research
|August 1, 2025
概括
研究人员发现了一种新型的TREX1抑制剂,可以增强干扰素信号传递并增强CD8+T细胞免疫力. 这种方法有望通过向STING通路来改善癌症免疫疗法.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 干扰素基因刺激剂 (STING) 激动剂面临癌症免疫治疗的发展挑战.
- 细胞质循环二核酸激活STING,而TREX1酶会降解这些分子.
- 确定促进干扰素 (IFN) 信号传递和抗瘤免疫力的替代途径至关重要.
研究的目的:
- 发现和评估一种新的TREX1抑制剂,以提高其增强IFN信号传递和抗瘤免疫力的潜力.
- 在临床前瘤模型中评估TREX1抑制的有效性.
- 探索TREX1向作为激活cGAS-STING通路的战略.
主要方法:
- 发现和免疫学测试一种新的小分子TREX1抑制剂.
- 使用工程可诱导的Trex1淘汰赛小鼠模型.
- 在体内评估抑制剂对IFN信号传递,CD8+T细胞免疫力和瘤进展的影响.
- 评估增强抗PD-1疗法的疗效.
主要成果:
- 这种新型的TREX1抑制剂在现场增强IFN信号传递.
- 抑制TREX1可以促进CD8+T细胞免疫力.
- 在小鼠中,系统性TREX1消灭导致了适度的炎症病理.
- 在临床前瘤模型中,TREX1抑制剂增强了抗PD-1疗效.
结论:
- 抑制TREX1是一种可行的策略,可以增强IFN信号和抗瘤免疫力.
- 向TREX1可能会克服癌症治疗中STING激动剂的局限性.
- 对TREX1抑制剂的全身传递显示了在癌症免疫治疗中临床应用的潜力.
更多相关视频
11:25Targeting Cysteine Thiols for in Vitro Site-specific Glycosylation of Recombinant Proteins
Published on: October 4, 2017
6.7K
07:41A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
Published on: February 20, 2018
9.0K
相关概念视频
cAMP-dependent Protein Kinase Pathways
6.6K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.6K
Transduction
116
Among the three main modes of HGT—transformation, conjugation, and transduction—transduction is unique in that it is mediated by bacteriophages, or bacterial viruses.Transduction occurs in two ways. Generalized transduction occurs during the lytic cycle of a bacteriophage infection. In this process, bacteriophages infect bacterial cells, replicate within them, and ultimately cause cell lysis, releasing newly assembled virions. Occasionally, random fragments of the bacterial genome...
116
GPCR Desensitization
6.5K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
6.5K
TGF - β Signaling Pathway
7.7K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.7K
Regulation of the Unfolded Protein Response
2.6K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.6K
MAPK Signaling Cascades
6.1K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.1K
